What was the market valuation of the France gamma knife market in 2024?

The market valuation of the France gamma knife market was $25.09 Million in 2024. Read More

What is the projected market valuation for the France gamma knife market in 2035?

The projected market valuation for the France gamma knife market is $45.0 Million in 2035. Read More

What is the expected CAGR for the France gamma knife market during the forecast period 2025 - 2035?

The expected CAGR for the France gamma knife market during the forecast period 2025 - 2035 is 5.45%. Read More

Which companies are the key players in the France gamma knife market?

Key players in the France gamma knife market include Elekta AB, Accuray Incorporated, Varian Medical Systems, Brainlab AG, MediTech, Shenzhen Huikang Medical Technology Co., Ltd., Nanjing Jinling Medical Equipment Co., Ltd., and Leksell Gamma Knife. Read More

What are the main disease indications for gamma knife treatments in France?

The main disease indications for gamma knife treatments in France include Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, and Others. Read More

What was the market value for Brain Metastasis treatment in 2024?

The market value for Brain Metastasis treatment was $5.0 Million in 2024. Read More

What is the projected market value for Cancer treatment by 2035?

The projected market value for Cancer treatment is expected to reach $15.0 Million by 2035. Read More

How does the market value for Trigeminal Neuralgia treatment compare to other indications?

The market value for Trigeminal Neuralgia treatment was $3.0 Million in 2024, which is lower compared to other indications like Cancer and Brain Metastasis. Read More

What anatomical areas are primarily targeted in the France gamma knife market?

The primary anatomical areas targeted in the France gamma knife market include the Head, Neck, and Others. Read More

What was the market value for the Neck anatomical segment in 2024?

The market value for the Neck anatomical segment was $8.0 Million in 2024. Read More

France Gamma Knife Market

ID: MRFR/HC/50654-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

France Gamma Knife Market Research Report: Size, Share, Trend Analysis By Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others) and By Anatomy (Head, Neck, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Disease Indication (USD Million)
  1. 4.1.1 Brain Metastasis
  2. 4.1.2 Cancer
  3. 4.1.3 Arteriovenous Malformation
  4. 4.1.4 Trigeminal Neuralgia
  5. 4.1.5 Others
2. 4.2 Pharmaceutical, BY Anatomy (USD Million)
  1. 4.2.1 Head
  2. 4.2.2 Neck
  3. 4.2.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Elekta AB (SE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Accuray Incorporated (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Varian Medical Systems (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Brainlab AG (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 MediTech (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Shenzhen Huikang Medical Technology Co., Ltd. (CN)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Nanjing Jinling Medical Equipment Co., Ltd. (CN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Leksell Gamma Knife (SE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY DISEASE INDICATION
3. 6.3 FRANCE MARKET ANALYSIS BY ANATOMY
4. 6.4 KEY BUYING CRITERIA OF PHARMACEUTICAL
5. 6.5 RESEARCH PROCESS OF MRFR
6. 6.6 DRO ANALYSIS OF PHARMACEUTICAL
7. 6.7 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
8. 6.8 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
9. 6.9 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
10. 6.10 PHARMACEUTICAL, BY DISEASE INDICATION, 2024 (% SHARE)
11. 6.11 PHARMACEUTICAL, BY DISEASE INDICATION, 2024 TO 2035 (USD Million)
12. 6.12 PHARMACEUTICAL, BY ANATOMY, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY ANATOMY, 2024 TO 2035 (USD Million)
14. 6.14 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DISEASE INDICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY ANATOMY, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France Pharmaceutical Market Segmentation

Pharmaceutical By Disease Indication (USD Million, 2025-2035)

Brain Metastasis
Cancer
Arteriovenous Malformation
Trigeminal Neuralgia
Others

Pharmaceutical By Anatomy (USD Million, 2025-2035)

Head
Neck
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”